triazoles has been researched along with Autoimmune Diabetes in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 16 (69.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartola, LD; Giampietro, C; Giampietro, O; Masoni, MC; Matteucci, E | 1 |
| Hari Kumar, KV; Prusty, P; Shaikh, A | 1 |
| Cabrera, SM; Colvin, SC; Maier, B; Mirmira, RG; Nadler, JL; Tersey, SA | 1 |
| Cimburek, Z; Dovolilová, E; Saudek, F; Vargová, L; Vojtová, L; Zacharovová, K | 1 |
| Cappuccio, F; Ceriello, A; Genovese, S; Schnell, O; Standl, E; Valensi, P | 1 |
| Costantino, F; Di Biasi, C; di Coste, A; Duse, M; Ernesti, I; Melengu, T; Savastano, V; Schiavi, L; Tarani, L | 1 |
| Huang, G; Leslie, RD; Li, X; Liu, L; Long, Z; Wang, X; Xiang, Y; Yang, L; Zhao, Y; Zhou, Z | 1 |
| Ambrósio, AF; Fernandes, R; Gonçalves, A; Leal, E; Marques, C; Reis, F; Ribeiro, CF | 1 |
| Gottschalk, M; Griffin, KJ; Kyllo, JH; Rabinovitch, A; Thompson, PA | 1 |
| Hitomi, H; Ichihara, A; Kitada, K; Kobori, H; Morimoto, S; Morita, T; Nakano, D; Nishiyama, A; Shiojima, I | 1 |
| Anderson, DG; Aresta-Dasilva, S; Bader, AR; Bochenek, MA; Chen, M; Doloff, JC; Gandham, S; Greiner, DL; Gürtler, M; Hollister-Lock, J; Jhunjhunwala, S; Langan, E; Langer, R; Li, J; McGarrigle, JJ; Melton, DA; Millman, JR; Oberholzer, J; Olejnik, K; Pagliuca, FW; Tam, HH; Vegas, AJ; Veiseh, O; Weir, GC | 1 |
| Hancianu, M; Kolecka, A; Marangoci, N; Mares, M; Minea, B; Nastasa, V; Pinteala, M; Rosca, I | 1 |
| Costantino, F; Di Biasi, C; Friederici, D; Notheis, G; Pasquino, AM; Tarani, L; Venditti, M; Wintergerst, U | 1 |
| Seissler, J | 1 |
| Doudet, DJ; Kim, SJ; McIntosh, CH; Nian, C | 1 |
| DiBartolo, MA; Kelley, PS | 1 |
| Ellis, SL; Garg, SK; Hazenfield, RM; Moser, EG; Rodionova, AS; Snell-Bergeon, JK | 1 |
| Gupta, S | 1 |
| Caldeira, EJ; da Silva Faria, AL; da Silva, RE; Dias, MA; Ferreira Junior, RS; Leme, VB; Mâncio, RD; Mayoral, EE | 1 |
| Belohradsky, BH; Costantino, F; Friederici, D; Jansson, A; Notheis, G; Reinhardt, D; Rosenecker, J; Schweinitz, DV; Seger, R; Tarani, L; Wintergerst, U | 1 |
| Campbell, KM; Taylor, JR | 1 |
| Baskin, DG; Braquet, P; Goodner, CJ; Jobe, LW; Lernmark, A; Ubungen, R | 1 |
| Biggs, F; Warnock, JK | 1 |
4 review(s) available for triazoles and Autoimmune Diabetes
| Article | Year |
|---|---|
Type 1 diabetes and cardiovascular disease.
Topics: Antihypertensive Agents; Autonomic Nervous System Diseases; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Drug Therapy, Combination; Exenatide; Exercise Therapy; Glucagon-Like Peptide 1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Insulin; Oxidative Stress; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2013 |
Rhinocerebral zygomycosis with pansinusitis in a 14-year-old girl with type 1 diabetes: a case report and review of the literature.
Topics: Adolescent; Antifungal Agents; Blindness; Diabetes Mellitus, Type 1; Disease Progression; Electromyography; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Meningitis, Fungal; Nose Diseases; Opportunistic Infections; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome; Triazoles; Zygomycosis | 2013 |
Immunotherapies in diabetes mellitus type 1.
Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Azathioprine; Basiliximab; Chaperonin 60; Cyclosporine; Daclizumab; Diabetes Mellitus, Type 1; Diet; Etanercept; Exenatide; Fatty Acids, Unsaturated; Glutamate Decarboxylase; Humans; Hypoglycemic Agents; Immunoconjugates; Immunoglobulin G; Immunosuppressive Agents; Insulin; Interferon-alpha; Interleukin 1 Receptor Antagonist Protein; Islets of Langerhans Transplantation; Niacinamide; Peptide Fragments; Peptides; Primary Prevention; Pyrazines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rituximab; Secondary Prevention; Sitagliptin Phosphate; Tertiary Prevention; Triazoles; Venoms; Vitamin D; Vitamins | 2012 |
Diabetes drug update: how 4 new options stack up.
Topics: Administration, Inhalation; Amyloid; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Exenatide; Family Practice; Female; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Islet Amyloid Polypeptide; Male; Peptides; Prognosis; Pyrazines; Randomized Controlled Trials as Topic; Risk Assessment; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms | 2007 |
5 trial(s) available for triazoles and Autoimmune Diabetes
| Article | Year |
|---|---|
Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Body Weight; Cholesterol, LDL; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles | 2013 |
Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
Topics: Adult; Diabetes Mellitus, Type 1; Exenatide; Female; Humans; Insulin; Male; Peptides; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms; Young Adult | 2013 |
Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Prospective Studies; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2014 |
Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial.
Topics: Adolescent; Adult; Child; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Lansoprazole; Male; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; United States | 2014 |
Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial.
Topics: Adult; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles; United States | 2011 |
14 other study(ies) available for triazoles and Autoimmune Diabetes
| Article | Year |
|---|---|
Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Female; Histone Deacetylase Inhibitors; Hydroxamic Acids; Insulin-Secreting Cells; Mice; Mice, Inbred NOD; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1; Triazoles; Vorinostat | 2013 |
The effects of DPP-IV inhibition in NOD mice with overt diabetes.
Topics: Animals; Diabetes Mellitus, Type 1; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Female; Islets of Langerhans; Lymph Nodes; Mice; Mice, Inbred NOD; Pyrazines; Sitagliptin Phosphate; Spleen; T-Lymphocyte Subsets; Time Factors; Triazoles | 2013 |
Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Topics: Animals; Apoptosis; Biomarkers; Blood-Retinal Barrier; Blotting, Western; Cell Death; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Enzyme-Linked Immunosorbent Assay; Immunoenzyme Techniques; Inflammation; Male; Neurons; Pyrazines; Rats; Rats, Wistar; Retina; Sitagliptin Phosphate; Triazoles | 2014 |
Chelation of dietary iron prevents iron accumulation and macrophage infiltration in the type I diabetic kidney.
Topics: Animals; Benzoates; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Deferasirox; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Knockout Techniques; Iron; Iron Chelating Agents; Iron, Dietary; Kidney; Macrophages; Male; Mice; Mice, Inbred C57BL; Triazoles | 2015 |
Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice.
Topics: Alginates; Animals; Blood Glucose; Blotting, Western; C-Peptide; Cell Culture Techniques; Cell Differentiation; Cell Transplantation; Chromatography, Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Embryonic Stem Cells; Flow Cytometry; Fluorescent Antibody Technique; Foreign-Body Reaction; Humans; Hydrogels; Immunocompetence; Insulin; Insulin-Secreting Cells; Mice; Microscopy, Confocal; Microscopy, Phase-Contrast; Morpholines; Polymers; Tandem Mass Spectrometry; Triazoles | 2016 |
Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus.
Topics: Antifungal Agents; Candida; Candidiasis, Oral; Diabetes Complications; Diabetes Mellitus, Type 1; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Romania; Triazoles | 2016 |
Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl.
Topics: Antifungal Agents; Central Nervous System Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Follow-Up Studies; Humans; Mucormycosis; Nose Diseases; Orbital Diseases; Time Factors; Treatment Outcome; Triazoles | 2009 |
[Future therapeutic options and their indications: transplantation and the possibilities of regenerative therapy for diabetes type 1].
Topics: Adamantane; Animals; Diabetes Mellitus, Type 1; Exenatide; Humans; Insulin-Secreting Cells; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Nitriles; Peptides; Pyrazines; Pyrrolidines; Regeneration; Sitagliptin Phosphate; Stem Cell Transplantation; Transplantation, Heterologous; Triazoles; Venoms; Vildagliptin | 2008 |
Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation.
Topics: Animals; Diabetes Mellitus, Type 1; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Graft Rejection; Graft Survival; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred NOD; Pyrazines; Sitagliptin Phosphate; T-Lymphocytes; Transplantation, Isogeneic; Triazoles | 2009 |
Rhino-orbital-cerebral mucormycosis (ROCM): a comprehensive case review.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Diseases; Debridement; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus, Type 1; Disease Progression; Eye Infections, Fungal; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Mucormycosis; Nose Diseases; Orbital Diseases; Tomography, X-Ray Computed; Triazoles | 2011 |
Dipeptidyl peptidase IV inhibitor improves the salivary gland histology of spontaneously diabetic mice.
Topics: Analysis of Variance; Animals; Blood Glucose; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Extracellular Matrix; Female; Homeostasis; Hypoglycemic Agents; Mice; Mice, Inbred NOD; Microscopy, Polarization; Pyrazines; Salivary Glands; Sitagliptin Phosphate; Triazoles | 2013 |
Posaconazole for treatment of refractory invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Aspergillus nidulans; Central Nervous System Fungal Infections; Child; Child, Preschool; Diabetes Mellitus, Type 1; Drug Resistance, Fungal; Female; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Lung Diseases, Fungal; Male; Mucormycosis; Rhizopus; Sinusitis; Treatment Outcome; Triazoles | 2006 |
Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730.
Topics: Age Factors; Animals; Autoimmune Diseases; Azepines; Diabetes Mellitus, Type 1; Insulin; Islets of Langerhans; Male; Platelet Activating Factor; Rats; Rats, Inbred BB; Tetrazoles; Thienopyridines; Thyroid Gland; Thyroiditis, Autoimmune; Triazoles | 1993 |
Nefazodone-induced hypoglycemia in a diabetic patient with major depression.
Topics: Antidepressive Agents, Second-Generation; Blood Glucose; Depressive Disorder; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemia; Middle Aged; Piperazines; Triazoles | 1997 |